Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma

24 May 2021

Abstract excerpt

N6-methyladenosine (m6A) methyltransferase has been shown to be an oncogene in a variety of cancers. Nevertheless, the relationship between the long non-coding RNAs (lncRNAs) and hepatocellular carcinoma (HCC) remains elusive. We integrated the gene expression data of 371 HCC and 50 normal tissues from The Cancer Genome Atlas (TCGA) database. Differentially expressed protein-coding genes (DE-PCGs)/lncRNAs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to RNA modifications and cancer
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34027555
DOI: 10.1042/bsr20210760

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinomaPMID 34027555Read ↗

Significance of m 6A Methyltransferase‑Related lncRNAs in the Prognosis and Immunotherapy of Hepatocellular CarcinomaSemantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity Read ↗

Gene Risk Signature of m6A Regulators, KIAA1429, YTHDF1, YTHDF2, METTL3 and Its Relationship with Immune Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

RNA m6A methylation regulator-mediated modification patterns and tumor microenvironment characterization in hepatocellular carcinomaSemantic proximity Read ↗

Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment ResponseSemantic proximity Read ↗

m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity Read ↗

The Significance of Prognostic m6A RNA Methylation Regulators in Tumor Immune Environment and Immune Therapy of Hepatocellular CarcinomaSemantic proximity Read ↗

M 6A-related genes characterization in hepatocellular cancer identifies prognostic relevant gene signaturesSemantic proximity Read ↗

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma ImmunotherapySemantic proximity Read ↗

Molecular phenotypic linkage between N6-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma.Semantic proximity Read ↗

Immune-Related DNA Methylation Data-Based Molecular Classification Associated with the Prognosis of Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.